First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

40 FDA enforcement actions

40 Total Recalls

0 Class I

40 Class II

0 Class III

Firm Details

Product Types: drug
States: AZ

All Recalls

Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II: Risk 08/13/2021 drug

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.